5 Considerations To Help Differentiate Your Oncology Drug

An increasing number of oncology drugs are putting patient-reported outcomes on their label. Since 2012, 13 oncology drug labels have included PRO data.c
As a result, regulatory authorities have begun advising sponsors to collect information on how their drug affects patients' feelings and quality of life. By making this information accessible, it helps Healthcare Authorities, clinicians, and patients decide what drug they’ll want to use in their oncology treatment.
For example, in 2020 the FDA launched Project Patient Voice. Being able to demonstrate a reduction in symptoms, potentially leading to improved quality of life will help your cancer treatment stand out in a highly competitive market. Review these points to help your cancer treatment stand out in a highly competitive market.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.